01:24 PM EDT, 05/07/2024 (MT Newswires) -- Cogent Biosciences ( COGT ) reported Q1 loss Tuesday of $0.62 per share, widening from a loss of $0.55 per share a year earlier.

Analysts polled by Capital IQ expected $0.51.

As expected, no revenue for the quarter ended March 31 was reported.

As of March 31, the company said it had $435.7 million in cash, cash equivalents and marketable securities, and expected it could fund operations into 2027.

Cogent shares were up nearly 2% in recent trading.

Price: 7.71, Change: +0.14, Percent Change: +1.78